ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design
Cardiology Journal · 29.12.2025 · 32 (6) · 695-703
DOI: 10.5603/cj.107098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Journal, online erschienen am 29.12.2025. Verfasst von Danuta Łoboda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland. dloboda…. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland. dloboda@sum.edu.pl.
- Department of Electrocardiology, Upper-Silesian Medical Centre in Katowice, Poland. dloboda@sum.edu.pl.
- Department of Microbiology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
- Department of Electrocardiology, Upper-Silesian Medical Centre in Katowice, Poland.
- Doctoral School of the Medical University of Silesia in Katowice, Poland.
- Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland.
ORCID-Profile: Danuta Łoboda, Denis Swolana, Michał Joniec, Sylwia Gładysz-Wańha, Michał Gibiński, Karolina Simionescu, Krzysztof S Gołba, Robert D Wojtyczka, Sławomir Wilczyński, Beata Sarecka-Hujar
Zitieren
APA
Łoboda, D., Swolana, D., Joniec, M., Gładysz-Wańha, S., Gibiński, M., Simionescu, K., Piłat, E., Gołba, K. S., Wojtyczka, R. D., Wilczyński, S., & Sarecka-Hujar, B. (2025). ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. Cardiology Journal, 32(6), 695-703. https://doi.org/10.5603/cj.107098
Vancouver
Łoboda D, Swolana D, Joniec M, Gładysz-Wańha S, Gibiński M, Simionescu K, et al. ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. Cardiology Journal. 2025;32(6):695-703. doi:10.5603/cj.107098
BibTeX
@article{oboda2025,
author = {Łoboda, Danuta and Swolana, Denis and Joniec, Michał and Gładysz-Wańha, Sylwia and Gibiński, Michał and Simionescu, Karolina and Piłat, Eugeniusz and Gołba, Krzysztof S and Wojtyczka, Robert D and Wilczyński, Sławomir and Sarecka-Hujar, Beata},
title = {ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design},
journal = {Cardiology Journal},
year = {2025},
volume = {32},
number = {6},
pages = {695--703},
doi = {10.5603/cj.107098}
}
EUVIMED